Increased CD4+ and CD8+ T lymphocyte and M1 macrophage infiltration and reduced numbers of CD4+ FOXP3+ T regulatory lymphocytes were observed after NP-GSDMA3 and Phe-BF3 administration, and these effects resulted in tumor regression 130 (Figure 4C). This evidence concerns the gene CD8A and neoplasm.